Literature DB >> 16612235

Role of leptin in blood pressure regulation and arterial hypertension.

Jerzy Bełtowski1.   

Abstract

Leptin is a 16-kDa protein secreted by white adipose tissue that is primarily involved in the regulation of food intake and energy expenditure. Plasma leptin concentration is proportional to the amount of adipose tissue and is markedly increased in obese individuals. Recent studies suggest that leptin is involved in cardiovascular complications of obesity, including arterial hypertension. Acutely administered leptin has no effect on blood pressure, probably because it concomitantly stimulates the sympathetic nervous system and counteracting depressor mechanisms such as natriuresis and nitric oxide (NO)-dependent vasorelaxation. By contrast, chronic hyperleptinemia increases blood pressure because these acute depressor effects are impaired and/or additional sympathetic nervous system-independent pressor effects appear, such as oxidative stress, NO deficiency, enhanced renal Na reabsorption and overproduction of endothelin. Although the cause-effect relationship between leptin and high blood pressure in humans has not been demonstrated directly, many clinical studies have shown elevated plasma leptin in patients with essential hypertension and a significant positive correlation between leptin and blood pressure independent of body adiposity both in normotensive and in hypertensive individuals. In addition, leptin may contribute to end-organ damage in hypertensive individuals such as left ventricular hypertrophy, retinopathy and nephropathy, independent of regulating blood pressure. Here, current knowledge about the role of leptin in the regulation of blood pressure and in the pathogenesis of arterial hypertension is presented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612235     DOI: 10.1097/01.hjh.0000222743.06584.66

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  60 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?

Authors:  Meera Penumetcha; Nadya Merchant; Sampath Parthasarathy
Journal:  J Med Food       Date:  2010-12-27       Impact factor: 2.786

3.  Association of plasma leptin concentrations with adiposity measurements in rural Chinese adolescents.

Authors:  Shanchun Zhang; Xin Liu; Wendy J Brickman; Katherine Kaufer Christoffel; Donald Zimmerman; Hui-Ju Tsai; Guoying Wang; Binyan Wang; Zhiping Li; Gengfu Tang; Xue Liu; Jianhua Yang; Xiping Xu; Xiaobin Wang
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

Review 4.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 5.  Sympathoinhibitory signals from the gut and obesity-related hypertension.

Authors:  Daniela M Sartor
Journal:  Clin Auton Res       Date:  2012-07-13       Impact factor: 4.435

6.  Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.

Authors:  Meltem Akcaboy; Serdar Kula; Tayfun Göktas; Bijen Nazlıel; Semiha Terlemez; Nurullah Celik; Bülent Celik; Necla Buyan
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

7.  Role of nitric oxide (NO) metabolism and inflammatory mediators in childhood obesity.

Authors:  András Hrabák; László Derzbach; Ildikó Csuka; Tamás Bajor; Anna Körner
Journal:  Inflamm Res       Date:  2011-08-27       Impact factor: 4.575

8.  Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.

Authors:  Carla R P Oliveira; Roberto Salvatori; Rafael A Meneguz-Moreno; Manuel H Aguiar-Oliveira; Rossana M C Pereira; Eugênia H A Valença; Vanessa P Araujo; Natália T Farias; Débora C R Silveira; Jose G H Vieira; Jose A S Barreto-Filho
Journal:  J Clin Endocrinol Metab       Date:  2009-12-16       Impact factor: 5.958

9.  Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension.

Authors:  Jerzy Bełtowski
Journal:  Curr Cardiol Rev       Date:  2010-02

Review 10.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.